Written | 2003-11 | Lisa Lee-Jones |
Tumour Molecular Genetics Group, Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XN, UK |
Identity |
ICD-Topo | C569 OVARY |
ICD-Morpho | 8590/1 Sex cord-stromal tumor, NOS |
Atlas_Id | 5223 |
Phylum | Female organs: Ovary::Sex cord stromal tumor |
WHO/OMS Classification | Female organs |
Note | Sex cord-stromal tumours develop from the gonadal stroma, and are a type of ovarian tumour. They account for 5-10 % of all ovarian neoplasms. |
Classification |
Ovarian sex cord-stromal tumours are subdivided into the following clinicopathological entities: |
Clinics and Pathology |
Etiology | There appear to be several established clinical syndromes associated with several subtypes of sex cord-stromal tumours.
2 theories account for the aetiology of sex cord-stromal tumours hypothesising that they develop either from: No definite aetiologies have been established for granulosa cell tumours, although chromosomal abnormalities and abnormal autocrine and endocrine signalling have been suggested. |
Epidemiology | The frequency of sex cord-stromal tumours is similar throughout the world. There does not appear to a racial predisposition, in contrast to epithelial ovarian cancers. Every year, 15-20,000 new cases of sex cord-stromal tumours are diagnosed in the USA. Sex cord-stromal tumours appear in any age group but usually in the 4th and 5th decades. Fibromas are usually detected in the fifth decade of life. The mean age of presentation of Leydig cell tumours is 50. The median age of diagnosis of adult granulosa cell tumours is 52, and is 53-years for theca cell tumours. Theca cell tumours account for 1 % of ovarian neoplasms, and are rarely diagnosed in women under 30-years of age, unless they have luteinized thecoma which is more apparent in younger women. However, Sertoli-Leydig cell tumours tend to present at a younger age, usually in the third decade of life. |
Clinics | Granulosa cell tumours usually follow a nonaggressive clinical course. However, they may become malignant or recur (up to 30 years after the initial diagnosis). 65% of granulosa cell tumours occur in postmenopausal females. Juvenile and adult granulosa cell tumours, fibromas, and Sertoli-Leydig cell tumours are usually unilateral. Granulosa-theca cell tumours are usually large and benign, with cystic degeneration (http://chorus.rad.mcw.edu/doc/00506). Intra-abdominal bleeding following rupture is often the presenting symptom of patients with granulosa cell tumour. Both adult and juvenile granulosa cell tumours are indolent. Approximately 10% of granulosa cell tumours occur in pregnant patients, and should be surgically removed at 16-18 weeks of gestation. The excess oestrogen produced by some stromal tumours, such as adult granulosa cell tumours and thecomas, causes isosexual precocious puberty, postmenopausal bleeding, menorrhagia, menometrorrhagia, amenorrhea, endometrial hyperplasia or cancer or fibrocystic breast disease (http://chorus.rad.mcw.edu/doc/00506). Thecomas usually develop in postmenopausal women, on average grow to 7-8 cm, and >97% of cases are unilateral. Most thecomas are hormone producing and cause postmenopausal bleeding in two-thirds of patients. Luteinized thecomas are usually androgenic, and these tend to present in younger women. Approximately 40% of patients with Sertoli-Leydig cell tumours and most patients with Leydig cell tumours show virilization. This is attributable to the Leydig cells which produce androgens. Lipid cell tumours usually cause virilization. A subset of patients with Sertoli-Leydig cell tumours secrete excess oestrogen. |
Pathology | All ovarian sex cord-stromal tumours are derived from the stroma of the developing ovary. The gonadal stoma is primitive, and consequently can develop in a testicular or ovarian differentiation pathway. Adult and Juvenile Granulosa cell tumour The gross appearance of juvenile granulosa cell tumours is similar to the adult counterparts-both comprise a mixture of solid and cystic components with many haemorrhagic areas. However the similarity ceases at the gross level, as morphologically both types differ greatly. Juvenile granulosa cell tumours contain round hyperchromatic nuclei, nuclear grooves are usually absent, severe nuclear atypia, contain more mitotic figures, more cytoplasm (which is dense). Gross image of granulosa cell tumour can be viewed at: Microscopic images at varying magnification powers can be viewed at: Fibromas Gross appearance of an ovarian fibroma can be viewed at: Histological images of fibromas can be viewed at: Thecomas Sertoli cell tumours Sertoli-Leydig cell tumours Less than 5% of Sertoli-Leydig tumours are malignant. Leydig cell tumours Lipid cell tumours Gynandroblastoma Sex cord tumour with annular tubules (SCTAT) |
Treatment | No effective treatment is available for metastatic lipid cell tumours. |
Evolution | 20% of lipid cell tumours metastasise. In the low percentage of granulosa cell tumours showing aggressive behaviour, any organ can be affected by metastatic disease, although it is usually confined to the pelvis and abdomen. |
Prognosis | The prognosis of sex-cord-stromal tumours is good, as these tumours usually present when confined to a single ovary, and are responsive to chemotherapy.
|
Cytogenetics |
Cytogenetics Morphological | Trisomy 12 is a recurrent finding, often as the sole anomaly in benign sex cord-stromal tumours including fibromas, fibrothecomas, thecomas, granulosa cell tumours. The consistent occurrence of trisomy 12 in different subtypes of sex cord-stromal tumours suggests a common mechanism of oncogenesis within this diverse group of neoplasms. Numerical abnormalities of chromosome 12 can readily be demonstrated by interphase cytogenetics. Trisomy 12 and 14, and monosomy 22 are the characteristic recurrent cytogenetic aberrations in granulosa cell tumours. There has been a single case of a Sertoli cell tumour in which cytogenetics was performed. Supernumerary i(1q) was present as the sole abnormality. Monosomy 22 was identified as the sole anomaly in a mixed germ cell-sex cord-stromal tumour in the ovary, by both karyotyping and CGH, which may suggest a common pathogenetic mechanism for both tumour types. Monosomy 22 was also identified as the sole abnormality in a fibrothecoma. Monosomy 22 and trisomy 14 may be early events in the pathogenesis of adult granulosa cell tumour, and particularly adult granulosa-thecoma cell tumours. Other abnormalities found include: |
Cytogenetics Molecular | CGH and FISH analysis of an ovarian metastasising Sertoli-Leydig cell tumour demonstrated trisomy 8 as the sole anomaly, suggesting that the molecular pathogenesis of Sertoli-Leydig cell tumours differs from the other subtypes of sex cord-stromal tumours. In a study, FISH using DNA-specific probes for chromosome 12, 17, 22 and X on granulosa cell tumours revealed monosomy 22 in 6/20; trisomy 12 in 5/20; monosomy X in 2/20 and monosomy 17 in 1/20. They also analysed this series of tumours by CGH and identified gains of chromosome 12 (6/20) and 14 (6/20) and losses of chromosome 22 (7/20) and X (1/20) as the predominant findings. These findings corroborate previous reports of the prevalence of trisomy 12 and 14 and monosomy 22 in granulosa cell tumours. |
Genes involved and Proteins |
Note | Involvement of the follicle stimulating hormone receptor, FSHR, gene in granulosa cell tumours has now been excluded. An initial study found mutations in 9 out of 13 sex cord tumours, which were later shown to arise from contamination in the tissue processing procedures. Other studies have confirmed the absence of somatic mutations in the FSHR in sex cord-stromal tumours, and in particular granulosa cell tumours. Activating mutations of the G-protein subunit, G-alpha I-2, have been found in 30% of ovarian sex cord tumours, however none were found in a series of 13 granulosa cell tumours. Data for involvement of the mutations in G-alpha I-2 (Gia2) gene, in ovarian granulosa cell tumours is contradictory. However, 2 studies have excluded any major involvement of this gene in the genesis of ovarian granulosa cell tumours. As discussed earlier, sex cord tumours with annular tubules are present at increased frequency in individuals with PJS, which is caused by germline inactivating mutations of the STK11 gene at 19p13.3. A study investigated whether LOH was present in 2 cases of PJS associated sex cord-stromal tumours, and in 5 sex cord-stromal tumours in individuals without PJS. LOH was identified in both tumours associated with PJS. Neither LOH nor somatic mutations of STK11 were present in the sporadic tumours. Immunohistochemistry has demonstrated that 32/33 granulosa cell tumours, and 10/11 Sertoli-Leydig cell tumours show inhibin alpha (INHA) immunopositivity, and 18/33 granulosa cell tumours and 6/11 Sertoli-Leydig cell tumours MIC2 (CD99 antigen) immunopositivity. Knockout mouse models null for the INHA gene develop granulosa cell tumours suggesting that this gene may act as a tumour suppressor gene. To find supporting evidence that this was the case in human granulosa cell tumours, It has been investigated whether LOH of the INHA locus at 2q33-qter was evident in a series of 17 granulosa cell tumours. However LOH was found in only one case, suggesting that this gene does not function as a tumour suppressor gene in granulosa cell tumours in human, contrary to the findings in the mouse model. However this supports the observation of elevated expression of inhibin which has been reported previously in these tumours. Thus there appears to be an apparent dichotomy between the human granulosa cell tumour and the mouse models. A study to address whether trisomy 12 was associated with amplification of the KRAS2 oncogene (12p12.1) demonstrated no relationship in 2 fibromas and 1 granulosa cell tumour with trisomy 12 (taking the ploidy level into account). Cyclin D2 (CCND2) has been suggested as the candidate gene on 12p, and has been reported to demonstrate increased expression. Granulosa cell tumours demonstrated increased expression of FSHR, CCND2, RII-beta and COX-2 (PTGS2), whereas they showed decreased expression of SGK and LHCGR (luteinizing hormone/choriogonadotropin receptor) compared to normal ovarian tissue by RT-PCR. Altered expression levels of the following genes have also been found in granulosa cell tumours: Mullerian inhibiting substance; inhibin; p53; ERBB2; and MYC. A role for the INK4 family of cyclin-dependent kinase inhibitors has also been suggested in granulosa cell tumours. The role of mutations of WT1 in sex cord-stromal tumours was investigated. Of 11 granulosa cell tumours, 3 Leydig cell tumours and 1 Sertoli-Leydig cell tumour, none harboured a mutation in the zinc finger domain where >90% of WT1 mutations are found in sporadic Wilms' tumours, despite most of the tumours expressing WT1 mRNA. However loss of the normal wild type allele of WT1 was observed in a granulosa cell tumour present in a patient with Denys-Drashattributable to a germline mutation of WT1. Studies on the role of TP53 mutations in granulosa cell tumours have been contradictory. It was found that over-expression of TP53 was not characteristic of 19 ovarian granulosa cell tumours; whereas other workers found a correlation between expression of mutated TP53 with poor prognosis, which was supported by other findings. Neither point mutations (exons 5-8 analysed only), nor LOH of TP53 were evident in a series of 17 granulosa cell tumours, suggesting that they have a distinct molecular pathogenesis to that of epithelial ovarian tumours. Mutations outside the hotspot exon 5-8 were not excluded by their study, but are unlikely to be significant since an association between TP53 and granulosa cell tumour by immunohistochemistry was not demonstrated in th efirst study. |
Bibliography |
Prognostic significance of p53 expression in ovarian granulosa cell tumors. |
Ala-Fossi SL, Mäenpää J, Aine R, Koivisto P, Koivisto AM, Punnonen R |
Gynecologic oncology. 1997 ; 66 (3) : 475-479. |
PMID 9299263 |
Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors. |
Arcellana-Panlilio MY, Egeler RM, Ujack E, Magliocco A, Stuart GC, Robbins SM, Coppes MJ |
Genes, chromosomes & cancer. 2002 ; 35 (2) : 176-181. |
PMID 12203782 |
The nevoid basal cell carcinoma syndrome: genetics and mechanism of carcinogenesis. |
Bale AE |
Cancer investigation. 1997 ; 15 (2) : 180-186. |
PMID 9095215 |
Inhibin and ovarian cancer. |
Burger HG, Baillie A, Drummond AE, Healy DL, Jobling T, Mamers P, Robertson DM, Susil B, Cahir N, Shen Y, Verity K, Fuller PJ, Groome NP, Findlay JK |
Journal of reproductive immunology. 1998 ; 39 (1-2) : 77-87. |
PMID 9786454 |
FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. |
Chu S, Rushdi S, Zumpe ET, Mamers P, Healy DL, Jobling T, Burger HG, Fuller PJ |
Molecular human reproduction. 2002 ; 8 (5) : 426-433. |
PMID 11994539 |
Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome. |
Connolly DC, Katabuchi H, Cliby WA, Cho KR |
The American journal of pathology. 2000 ; 156 (1) : 339-345. |
PMID 10623683 |
Analysis of WT1 in granulosa cell and other sex cord-stromal tumors. |
Coppes MJ, Ye Y, Rackley R, Zhao XL, Liefers GJ, Casey G, Williams BR |
Cancer research. 1993 ; 53 (12) : 2712-2714. |
PMID 8504409 |
Numerical chromosome aberrations in fibrothecoma. |
Dal Cin P, Moerman P, De Wever I, Van den Berghe H |
Tumori. 1992 ; 78 (2) : 140-142. |
PMID 1326140 |
Monosomy 22 in a fibrothecoma. |
Dal Cin P, Qi H, Pauwels P, Backx C, Van den Berghe H |
Cancer genetics and cytogenetics. 1997 ; 99 (2) : 129-131. |
PMID 9398868 |
Oxyphilic Sertoli cell tumor of the ovary: a report of three cases, two in patients with the Peutz-Jeghers syndrome. |
Ferry JA, Young RH, Engel G, Scully RE |
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 1994 ; 13 (3) : 259-266. |
PMID 7523322 |
Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. |
Fletcher JA, Gibas Z, Donovan K, Perez-Atayde A, Genest D, Morton CC, Lage JM |
The American journal of pathology. 1991 ; 138 (3) : 515-520. |
PMID 2000932 |
Inhibin subunit gene expression in ovarian cancer. |
Fuller PJ, Chu S, Jobling T, Mamers P, Healy DL, Burger HG |
Gynecologic oncology. 1999 ; 73 (2) : 273-279. |
PMID 10329046 |
No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. |
Fuller PJ, Verity K, Shen Y, Mamers P, Jobling T, Burger HG |
The Journal of clinical endocrinology and metabolism. 1998 ; 83 (1) : 274-279. |
PMID 9435455 |
Assessment of inhibin and p53 in granulosa cell tumors of the ovary. |
Gebhart JB, Roche PC, Keeney GL, Lesnick TG, Podratz KC |
Gynecologic oncology. 2000 ; 77 (2) : 232-236. |
PMID 10785470 |
No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors. |
Giacaglia LR, Kohek MB da F, Carvalho FM, Fragoso MC, Mendonca B, Latronico AC |
Fertility and sterility. 2000 ; 74 (5) : 992-995. |
PMID 11056247 |
- |
Goldman L |
Cecil Textbook of Medicine. 2000. |
A poorly differentiated Sertoli-Leydig cell tumour associated with an ovarian sex cord tumour with annular tubules in a woman with Peutz-Jeghers syndrome. |
Hales SA, Cree IA, Pinion S |
Histopathology. 1994 ; 25 (4) : 391-393. |
PMID 7835846 |
Numerical and structural chromosome abnormalities in an ovarian fibrothecoma. |
Izutsu T, Kudo T, Miura F, Nishiya I |
Cancer genetics and cytogenetics. 1995 ; 83 (1) : 84-86. |
PMID 7656212 |
Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. |
King LA, Okagaki T, Gallup DG, Twiggs LB, Messing MJ, Carson LF |
Gynecologic oncology. 1996 ; 61 (2) : 227-232. |
PMID 8626138 |
A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. |
Kotlar TJ, Young RH, Albanese C, Crowley WF Jr, Scully RE, Jameson JL |
The Journal of clinical endocrinology and metabolism. 1997 ; 82 (4) : 1020-1026. |
PMID 9100567 |
Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. |
Lane AH, Lee MM, Fuller AF Jr, Kehas DJ, Donahoe PK, MacLaughlin DT |
Gynecologic oncology. 1999 ; 73 (1) : 51-55. |
PMID 10094880 |
Inhibin as a marker for granulosa-cell tumors. |
Lappöhn RE, Burger HG, Bouma J, Bangah M, Krans M, de Bruijn HW |
The New England journal of medicine. 1989 ; 321 (12) : 790-793. |
PMID 2770810 |
Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. |
Ligtenberg MJ, Siers M, Themmen AP, Hanselaar TG, Willemsen W, Brunner HG |
The Journal of clinical endocrinology and metabolism. 1999 ; 84 (6) : 2233-2234. |
PMID 10372736 |
Overexpression of p53 is not a feature of ovarian granulosa cell tumors. |
Liu FS, Ho ES, Lai CR, Chen JT, Shih RT, Yang CH, Tsao CM |
Gynecologic oncology. 1996 ; 61 (1) : 50-53. |
PMID 8626117 |
Trisomy 8 as sole karyotypic aberration in an ovarian metastasizing Sertoli-Leydig cell tumor. |
Manegold E, Tietze L, Günther K, Fleischer A, Amo-Takyi BK, Schröder W, Handt S |
Human pathology. 2001 ; 32 (5) : 559-562. |
PMID 11381376 |
Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. |
Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A |
Nature. 1992 ; 360 (6402) : 313-319. |
PMID 1448148 |
Characteristic pattern of genetic aberrations in ovarian granulosa cell tumors. |
Mayr D, Kaltz-Wittmer C, Arbogast S, Amann G, Aust DE, Diebold J |
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2002 ; 15 (9) : 951-957. |
PMID 12218213 |
Trisomy 12 and 4 in a thecoma of the ovary. |
Mrózek K, Limon J, Debniak J, Emerich J |
Gynecologic oncology. 1992 ; 45 (1) : 66-68. |
PMID 1318257 |
- |
Noble J Eds |
Textbook of Primary Care Medicine.. |
Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease). |
Papageorgiou T, Stratakis CA |
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2002 ; 12 (4) : 337-347. |
PMID 12144681 |
Isochromosome 1q as the sole karyotypic abnormality in a Sertoli cell tumor of the ovary. |
Pejovic T, Heim S, Alm P, Iosif S, Himmelmann A, Skjaerris J, Mitelman F |
Cancer genetics and cytogenetics. 1993 ; 65 (1) : 79-80. |
PMID 8431922 |
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. |
Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L |
Cell. 1991 ; 67 (2) : 437-447. |
PMID 1655284 |
Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas. |
Riopel MA, Perlman EJ, Seidman JD, Kurman RJ, Sherman ME |
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 1998 ; 17 (1) : 46-53. |
PMID 9475192 |
Inhibin forms in serum from postmenopausal women with ovarian cancers. |
Robertson DM, Cahir N, Burger HG, Mamers P, Groome N |
Clinical endocrinology. 1999 ; 50 (3) : 381-386. |
PMID 10435065 |
Conservative treatment of recurrent ovarian fibromas in a young patient affected by Gorlin syndrome. |
Seracchioli R, Bagnoli A, Colombo FM, Missiroli S, Venturoli S |
Human reproduction (Oxford, England). 2001 ; 16 (6) : 1261-1263. |
PMID 11387302 |
Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. |
Shashi V, Golden WL, von Kap-Herr C, Andersen WA, Gaffey MJ |
Gynecologic oncology. 1994 ; 55 (3 Pt 1) : 349-354. |
PMID 7835773 |
Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors. |
Shen Y, Mamers P, Jobling T, Burger HG, Fuller PJ |
The Journal of clinical endocrinology and metabolism. 1996 ; 81 (11) : 4159-4161. |
PMID 8923876 |
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. |
Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA |
Nature. 1996 ; 384 (6608) : 470-474. |
PMID 8945475 |
Peutz-Jeghers syndrome associated with precocious puberty. |
Solh HM, Azoury RS, Najjar SS |
The Journal of pediatrics. 1983 ; 103 (4) : 593-595. |
PMID 6620020 |
Monosomy 22 in a mixed germ cell-sex cord-stromal tumor of the ovary. |
Speleman F, Dermaut B, De Potter CR, Van Gele M, Van Roy N, De Paepe A, Laureys G |
Genes, chromosomes & cancer. 1997 ; 19 (3) : 192-194. |
PMID 9219001 |
Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome. |
Srivatsa PJ, Keeney GL, Podratz KC |
Gynecologic oncology. 1994 ; 53 (2) : 256-264. |
PMID 8188091 |
Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization. |
Taruscio D, Carcangiu ML, Ward DC |
Diagnostic molecular pathology : the American journal of surgical pathology, part B. 1993 ; 2 (2) : 94-98. |
PMID 8269283 |
[Ovarian fibroma. Report of two cases; familial incidence?] |
Valle Virgen O, Valdés Banda-Gó F, Valenzuela Espinoza A |
Ginecologia y obstetricia de Mexico. 1997 ; 65 : 442-445. |
PMID 9432477 |
Monosomy 22 and trisomy 14 may be early events in the tumorigenesis of adult granulosa cell tumor. |
Van den Berghe I, Dal Cin P, De Groef K, Michielssen P, Van den Berghe H |
Cancer genetics and cytogenetics. 1999 ; 112 (1) : 46-48. |
PMID 10432935 |
Loss of heterozygosity at the alpha-inhibin locus on chromosome 2q is not a feature of human granulosa cell tumors. |
Watson RH, Roy WJ Jr, Davis M, Hitchcock A, Campbell IG |
Gynecologic oncology. 1997 ; 65 (3) : 387-390. |
PMID 9190962 |
Trisomy 12 and K-ras-2 amplification in human ovarian tumors. |
Yang-Feng TL, Li SB, Leung WY, Carcangiu ML, Schwartz PE |
International journal of cancer. Journal international du cancer. 1991 ; 48 (5) : 678-681. |
PMID 2071229 |
Sertoli cell tumor causing precocious puberty in a girl with Peutz-Jeghers syndrome. |
Zung A, Shoham Z, Open M, Altman Y, Dgani R, Zadik Z |
Gynecologic oncology. 1998 ; 70 (3) : 421-424. |
PMID 9790799 |
Citation |
This paper should be referenced as such : |
Lee-Jones, L |
Ovary: Sex cord-stromal tumors |
Atlas Genet Cytogenet Oncol Haematol. 2004;8(1):46-51. |
Free journal version : [ pdf ] [ DOI ] |
On line version : http://AtlasGeneticsOncology.org/Tumors/OvarSexCordStromID5223.html |
Other genes implicated (Data extracted from papers in the Atlas) [ 1 ] |
Genes | APAF1 |
External links |
arrayMap | Topo ( C56) arrayMap ((UZH-SIB Zurich) [auto + random 100 samples .. if exist ] [tabulated segments] |
Disease database | Ovary: Sex cord-stromal tumors |
REVIEW articles | automatic search in PubMed |
Last year articles | automatic search in PubMed |
© Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Mon Dec 14 18:30:38 CET 2020 |
For comments and suggestions or contributions, please contact us